| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jun 19, 2026 | Seoul National University Hospital to Expand Global K-Bio Collaboration at BIO USA 2026 | SAN DIEGO and SEOUL, South Korea, June 19, 2026 /PRNewswire/ -- Seoul National University Hospital (SNUH) will take a major step toward expanding K-Bio's global presence and international collaboration at BIO International Convention 2026 (... |
| Jun 15, 2026 | Secretary Pablos Leads Texas Delegation At 2017 BIO International Conference | Secretary Pablos participates in a panel discussion
at the 2017 BIO International Conference in
San Diego.
From left to right: Bryan Daniel, Executive Director
for Economic Development for the Office of
Governor Greg Abbott, Rolando Pablos,... |
| Jan 16, 2026 | Making U.S. biotech more competitive with China’s could help rare disease patients, experts say | To share your story, or find out how to get involved with CNBC Cures, email [email protected]
China is pumping money into its biotech industry, helping launch a new wave of labs and incubators in the country.
Experts say this could slow d... |
| Oct 17, 2025 | New leadership drives growth in biotech and AI startups |
Mark Pruzanski, a renowned physician entrepreneur is the newly appointed Chief Executive Officer of Alentis, a clinical-stage biotechnology company pioneering first-in-class antibodies and antibody-drug conjugates (ADCs) targeting claudin-... |
| Aug 5, 2025 | iBIO Releases Inaugural Member Investor Portfolio Report Showcasing $1.24 Billion in Illinois Life Sciences Investment | Report highlights nearly 100 life science companies and investment trends as Chicago prepares to welcome BIO International Convention 2030
CHICAGO, Aug. 5, 2025 /PRNewswire-PRWeb/ -- The Illinois Biotechnology Innovation Organization (iBIO)... |
| Jun 13, 2025 | Province helps build global connections for B.C.’s life-sciences sector | CANADA, June 13 - B.C. will lead a delegation of companies to the BIO International Convention in Boston, Mass., to attract more investment to the province’s life-sciences sector and build relationships with other countries to help strength... |
| Feb 17, 2025 | Cereno Scientific: Pioneering New Frontiers in Rare Disease Treatment | Cereno Scientific is a beacon of hope in the biotech landscape. This innovative company is dedicated to developing treatments for rare cardiovascular and pulmonary diseases. With a focus on enhancing and extending life, Cereno is making str... |
| Feb 14, 2025 | Cereno Scientific to attend BIO-Europe Spring 2025 – a leading partnering event for life science in Europe | Cereno Scientific to attend BIO-Europe Spring 2025 – a leading partnering event for life science in Europe
Fri, Feb 14, 2025 08:00 CET Report this content
Cereno Scientific (Nasdaq First North: CRNO B), an innovative biotech pioneering trea... |
| Nov 8, 2024 | The Ripple Effect of Trump's Tariffs on the Food Industry | The recent victory of Donald Trump in the 2024 election has sent shockwaves through the food and beverage industry. His proposed tariffs, a cornerstone of his economic strategy, threaten to reshape the landscape of American agriculture and ... |
| Nov 7, 2024 | ‘Four more years of chaos…’ Food & ag organizations respond to Trump victory | A resounding win for Donald Trump in the US election is prompting enthusiasm in some quarters of the food industry and intense anxiety in others.
Given the lack of detail in the official Republican party platform on food and ag, meanwhile, ... |
| Sep 5, 2024 | New Season of "I am BIO" Podcast Explores Patient Stories, Weight Loss Drugs, Food Security, and More | Series delves into biotech breakthroughs, the people they help, and the global problems they solve
WASHINGTON, Sept. 5, 2024 /PRNewswire/ -- The Biotechnology Innovation Organization (BIO) will launch the fall season of the award-winning &q... |
| Sep 4, 2024 | Egret Therapeutics Announces Appointment of Ron Cohen, M.D. to its Board of Directors | Egret Therapeutics, a portfolio company of Turret Capital Management, is a clinical stage biotechnology company focused on function preservation post acute ischemic injury
NEW YORK, Sept. 4, 2024 /PRNewswire/ -- Egret Therapeutics today ann... |
| Aug 22, 2024 | Global Genes' Annual Week in RARE Event Heading to Kansas City | Global Genes
Global Genes is taking Week In RARE on the road to Kansas City, after having hosted this annual event in California for over 12 years. Moving the location annually will help make the event more accessible and equitable to the g... |
| Aug 16, 2024 | Moberg Pharma's Strategic Growth Amidst Financial Challenges | Moberg Pharma is navigating a complex landscape in the pharmaceutical industry. Their interim report for January to June 2024 reveals a company in transition. The numbers tell a story of both struggle and success. Net revenue reached SEK 4.... |
| Aug 13, 2024 | Moberg Pharma´s interim report January - June 2024 | Moberg Pharma´s interim report January - June 2024
Tue, Aug 13, 2024 08:00 CET Report this content
TERCLARA IS THE MARKET LEADER IN SWEDEN
SIX-MONTH PERIOD (JAN-JUNE 2024) Net revenue SEK 4.9 million (0) EBITDA SEK -12.7 million (-10.7) Ope... |
| Jun 4, 2024 | Fapon Biopharma Announces a Safer Immunotherapy for Cancers | SAN DIEGO, June 4, 2024 /PRNewswire/ -- At Bio International Convention 2024, which is taking place here in San Diego during June 3-6, Fapon Biopharma, an innovator in developing therapeutic antibodies and fusion proteins, has announced an ... |
| May 28, 2024 | Cereno Scientific participating at BIO 2024, June 3-6, San Diego | Cereno Scientific participating at BIO 2024, June 3-6, San Diego
Tue, May 28, 2024 08:34 CET Report this content
Cereno Scientific (Nasdaq First North: CRNO B), a pioneering biotech developing innovative treatments for rare and common cardi... |
| May 18, 2024 | Health | A mother’s loss launches a global effort to fight antibiotic resistance | “Diary Of A Dying Girl” excerpts Mallory Smith’s own writings, which chronicle her 13-year battle against an antibiotic-resistant lung infection. (Genaro Molina/Los Angeles Times/TNS)
On Tuesday, Random House published “Diary of a Dying Gir... |
| May 11, 2024 | Caliway to Present the Latest Clinical Advancements at 2024 BIO International Convention | NEW TAIPEI CITY, May 11, 2024 /PRNewswire/ -- Caliway Biopharmaceuticals (Caliway) is pleased to announce its participation to share the latest clinical advancements at the upcoming 2024 BIO International Convention on Wednesday, June 5th, ... |
| May 7, 2024 | Prevent Blindness to Host the 2024 ASPECT Patient Engagement and Advocacy Summit in Washington, D.C. | Prevent Blindness to host the 2024 ASPECT Patient Engagement and Advocacy Summit and Eyes on Capitol Hill event in Washington, D.C., May 14-16, 2024.
Three-day event brings together patients, care partners, and public health champions to ad... |
| May 1, 2024 | Prevent Blindness to Host 13th Annual Focus on Eye Health Summit, a Two-Day Virtual Interactive Event, with theme of "Being Seen and Heard" | Registration open for free 13th Annual Prevent Blindness Focus on Eye Health Summit, held virtually, July 10 and 11, 2024.
National nonprofit Prevent Blindness to hold the 2024 Focus on Eye Health Summit, a free virtual interactive event, J... |
| Mar 12, 2024 | Tonix Pharmaceuticals Announces Presentation at BIO-Europe Spring | |
| Aug 14, 2023 | Seattle company founded by Nobel Prize winner plans human tests for experimental COVID-19 drug | Cocrystal Pharma co-founder Roger Kornberg won the Nobel Prize in Chemistry for revealing the high-resolution structure of a protein complex called RNA Polymerase II, shown here. The complex controls the synthesis of RNA (in red) from a DNA... |
| Jun 22, 2023 | Emerging Investment Opportunities In Diabetes Treatment | Luis Berruga is the CEO of Global X ETFs. |
| Jun 7, 2023 | CSBI Releases the 2023 Life Sciences Workforce Trends Report at BIO International Convention | BOSTON, MASS., U.S.A., June 7, 2023/EINPresswire.com/ -- The Coalition of State Bioscience Institutes (CSBI) releases the 2023 Life Sciences Workforce Trends Report with TEConomy Partners this week at the 2023 BIO International Convention i... |
| Jun 5, 2023 | Trade mission to U.S. builds on momentum in B.C.’s life-sciences sector | CANADA, June 5 - To attract more investment to B.C.’s life-sciences sector so that more global health-care challenges can be solved locally, Brenda Bailey, Minister of Jobs, Economic Development and Innovation, is leading a trade mission to... |
| Jun 1, 2023 | ExpreS2ion to participate in upcoming events | ExpreS2ion to participate in upcoming events
Thu, Jun 01, 2023 12:00 CET Report this content
Hørsholm, Denmark, 1 June 2023 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") will participate and ... |
| May 31, 2023 | PharmaCircle to Showcase its New Business Intelligence Tool – Partnership Explorer – at BIO International | Finding global pharmaceutical product partnership and investment opportunities is now easier than ever.”
— Kurt Sedo, Vice President, Product DevelopmentSUNNY ISLES, FLORIDA, UNITED STATES, May 31, 2023/EINPresswire.com/ -- PharmaCircle wil... |
| May 30, 2023 | Greenberg Traurig’s Andrew (A.J.) Tibbetts to Participate in 2023 BIO International Convention | BOSTON (PRWEB) May 30, 2023
Andrew (A.J.) Tibbetts, shareholder at global law firm Greenberg Traurig, LLP, will moderate a panel, “IP for AI: Expanding a Biopharma IP Portfolio to Protect AI and Data Innovations,” at the 2023 BIO Internatio... |
| May 8, 2023 | PharmAbcine to participate in "BIO International Convention 2023" | DAEJEON, South Korea, May 8, 2023 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of fully human antibody therapeutics, announced today that the company will participate in t... |
| Feb 2, 2023 | BriSTAR Immunotech to Present at the BIO CEO & Investor Conference | BEIJING and TORONTO, Feb. 2, 2023 /PRNewswire/ -- BriSTAR Immunotech, a clinical-stage cell therapy company, announced today that its Chief Executive Officer, James Pan, Ph.D., will be presenting at the 25th BIO CEO & Investor Conferenc... |
| Jan 5, 2023 | Genomenon to Participate in BIO Partnering at JPM During J.P. Morgan Week 2023 | ANN ARBOR, Mich. (PRWEB) January 05, 2023
Genomenon, Inc., an AI-driven genomics company, announced today that it will participate in BIO Partnering at JPM, January 9-12, 2023 in San Francisco.
Details of the event are as follows:
Event: BI... |
| Dec 12, 2022 | First Wave BioPharma to Participate in BIO Partnering @ JPM During “J.P. Morgan Week 2023” | /EIN News/ -- BOCA RATON, Fla., Dec. 12, 2022 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. (NASDAQ: FWBI) (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, n... |
| Dec 8, 2022 | PharmAbcine to Participate in the 41th Annual J.P. Morgan Healthcare Conference and Biotech Showcase™ 2023 during JPM Week | DAEJEON, South Korea, Dec. 8, 2022 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next-generation antibody therapeutics, announced today that the Company is invited to pa... |
| Nov 30, 2022 | BiondVax announces Third Quarter 2022 Financial Results and Provides Business Update | /EIN News/ -- JERUSALEM, Nov. 30, 2022 (GLOBE NEWSWIRE) -- via InvestorWire – BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), which focuses on developing, manufacturing, and commercializing innovative immunotherapeutic products primarily for ... |
| Nov 10, 2022 | Biotechnology Industry Gets A Boost From Community College Degrees | Pictured: Dolores Grijalva a student in MiraCosta College's Biomanufacturing Bachelor's Degree ... [+] program, the first bachelor's degree of its kind at a community college. Mike Fino, MiraCosta College |
| Nov 8, 2022 | Michigan Life Sciences Establishments Grow at Rate Higher Than the National Average, Says New Report | Tenth Biennial TEConomy/BIO Report Released
Michigan’s ranking of total bio-industry employment remains in the upper tier nationally, and notably, the state outpaced the nation in the establishment of new organizations in several sectors.”
... |
| Oct 18, 2022 | BIO International Convention 2023 in the USA - book your place on the German joint booth now! | In the summer of 2023, the BIO International Convention will again be held as an on-site event (status October 2022) in Boston, USA, from June 5 to 8, 2023. For German companies, there will again be a joint booth, the German Pavilion, with ... |
| Oct 14, 2022 | Will the Taiwan Semiconductor Manufacturing Company of Drugs Be in East Asia? | On Aug. 25, President Biden signed the monumental $52.7 billion CHIPS and Science Act into law. The legislation is aimed to address the semiconductor manufacturing bottleneck in East Asia, namely the near-monopoly held on the industry by th... |
| Oct 12, 2022 | Gene-editing companies are growing thanks to fast-paced science, even as biotech faces a downturn | Marianne Ayala/Insider This story is available exclusively to Insider subscribers. Become an Insider and start reading now.
Redeem now
A handful of biotechs specializing in gene editing are charging ahead despite an industry downturn.
Inste... |
| Oct 6, 2022 | See the 14-slide pitch deck that Meliora Therapeutics used to raise $11 million toward its search for more precise and effective cancer treatments | Meliora Therapeutics This story is available exclusively to Insider subscribers. Become an Insider and start reading now.
Cancer treatments are difficult to develop and bring to market — the vast majority of them fail. The biotech Meliora T... |
| Aug 10, 2022 | Major drug price reforms head for Biden's signature as PhRMA weighs legal options | The fact that the new drug price negotiations for certain blockbuster Medicare drugs — due for a partisan thumbs up in the US House of Representatives on Friday and a signature from President Joe Biden soon after — don’t t... |
| Jul 26, 2022 | American Cancer Society’s VC arm partners with Third Rock on oncology companies | Cancer startups aren’t exactly underfunded — as a disease area, oncology has commanded investors’ attention for the last decade.
But the American Cancer Society sees gaps.
Unlock this article by subscribing to STAT+ and enjoy your first 30 ... |
| Jun 16, 2022 | BIO: 'Diversity candidates' and knowledge 'shortfalls': Women in biotech say 'I'm here to do my job' despite toxic tropes | The script at BIO this year could not have been more clear: Progress on diversity is being made, but more work needs to be done. Yet still, an undercurrent of biotech’s all-boys brand-of-old tugged at the heels of efforts to bolster those l... |
| Jun 15, 2022 | After 3 years away, BIO marked by first-time handshakes and a drive to survive a bear market’s claws | Six days after the World Health Organization officially declared COVID-19 a global pandemic on March 11, 2020, Shafique Virani, M.D., landed a brand new job.
Following a two-year stint leading a couple of subsidiaries of BridgeBio, the Roch... |
| Jun 14, 2022 | While a small sampling, BIO's third diversity report provides 'benchmark' for data-focused industry to further analyze | The numbers are somewhat in and biotech diversity looks relatively similar to what it has been for years.
A 2021 sampling paints a very limited picture of the industry, with BIO’s third annual diversity report includ... |
| Jun 14, 2022 | ITJ’s CEO Maritza Diaz is to Attend the 2022 BIO International Convention for Partnering Opportunities | SAN DIEGO (PRWEB) June 14, 2022
The annual BIO International Convention, hosted by Biotechnology Innovation Organization (BIO), is the world’s largest industry gathering and brings together thousands of global biotechnology and biopharmaceu... |
| Jun 9, 2022 | Genomenon to Present at the 2022 BIO International Convention | ANN ARBOR, Mich. (PRWEB) June 09, 2022
Genomenon, Inc., an AI-driven genomics company, today announced that their Chief Scientific Officer, Mark Kiel, MD, PhD, will present on Monday, June 13, 2022 at 3:15 PM PT at the 2022 BIO Internationa... |
| May 24, 2022 | ExpreS2ion will participate in key industry and investor events | ExpreS2ion will participate in key industry and investor events
Tue, May 24, 2022 14:00 CET Report this content
Hørsholm, Denmark, May 24, 2022 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") w... |
| May 11, 2022 | PharmAbcine to participate in Jefferies Global Healthcare Conference and BIO International Convention | DAEJEON, South Korea, May 11, 2022 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next-generation antibody therapeutics, announced today that Dr. Jin-San Yoo, Chairman an... |
| Apr 12, 2022 | New antibiotics still a decade away unless policymakers, investors step up, AMR Action Fund CEO warns | A "broken" investment model means a new antibiotic may not reach the market for another decade, according to the head of a $1 billion Big Pharma-backed fund focused on the growing threat of drug-resistant bacteria.
Urgent market r... |
| Mar 30, 2022 | JADBio Selected among 20 EU Pioneering Technologies to Participate at BIO2022 | The EU Pavilion at BIO2022 will showcase European advanced biotech solutions that deliver a positive impact on the healthcare sector. HERAKLION, CRETE, GREECE, March 30, 2022 /EINPresswire.com/ -- The European Innovation Council (EIC) annou... |
| Mar 16, 2022 | 'Biotech sisterhood': 25 female CEOs find new ways to 'sponsor' the next generation at Arizona retreat | During a multihour hike in the hills of Arizona interspersed with cactus lessons, female CEOs fostered a "biotech sisterhood" aimed at lifting up their peers in the industry.
Two dozen female biotech CEOs—about half of the total i... |
| Mar 9, 2022 | Altos Labs’ Mega-Startup: Wretched Excess Or The Future Of Biotech…Or Both? | Alta Labs - the biggest biotech startup in history. Photo credit: Getty getty |
| Feb 24, 2022 | European Parliament Calls On EU To Recommend Meat-Free Diets to Fight Cancer | 3 Mins Read
The EU is being asked by the European Parliament to get behind promotion of meat reduction and full plant-based living as ways to reduce cancer risk. The move is designed to tackle the widespread issue of cancer within Europe, w... |
| Feb 15, 2022 | Industry wants new European pharma makeover to increase the continent's attractiveness for R&D | Last fall, with the world grappling — not all that well — with a global pandemic, anything might have seemed possible for the newly minted billionaires running Moderna. Their stock was trading north of $450 a share and the company was flyin... |
| Feb 15, 2022 | Scoop: Samantha Truex departs Atlas to head $200M OrbiMed-backed immunology startup | The small pain therapy player BioDelivery Sciences is getting scooped up in a $604 million buyout.
Collegium Pharmaceutical, a somewhat larger player in the pain arena that started the day with a market cap right at the buyout size, is doin... |
| Feb 15, 2022 | Scoop: Samantha Truex departs Atlas to head $200M OrbiMed-backed immunology startup | Roivant Sciences welcomed the newest addition to its family of “vants” on Monday during its fourth quarter and full-year 2021 update.
The biopharma unveiled Hemavant as its latest subsidiary, packaging the company launch with a compound in-... |
| Feb 15, 2022 | Padcev gets a shot at another indication — for invasive bladder cancer — thanks to initial data readout | Astellas and Seagen’s controversial nectin-4 ADC Padcev only got fully approved last summer, albeit with a black box warning against “severe and fatal cutaneous adverse reactions.” But in spite of other companies looking to make a better Pa... |
| Feb 15, 2022 | With FDA nods and third-shot OKs, Moderna and Pfizer boost vaccine ads – and booster messages | Now that both the Moderna and Pfizer-BioNTech Covid vaccines are FDA-approved, each also has the go-ahead to advertise their shots. While the focus was initially on simply encouraging vaccinations, Moderna and Pfizer now also have an eye on... |
| Feb 15, 2022 | Scoop: Samantha Truex departs Atlas to head $200M OrbiMed-backed immunology startup | Under a mountain of lawsuits alleging its talc-based products caused cancer, J&J attempted to dig itself out by spinning the liabilities into a separate company and filing for bankruptcy back in October. But on Monday, plaintiffs kicked... |
| Feb 15, 2022 | Industry wants new European pharma makeover to increase the continent's attractiveness for R&D | Super Bowl ads aren’t typically a last-minute buy. Getting a spot before inventory sells out is usually an issue, but so is taking the time to create a world-is-watching TV spot. Diagnostics tech company Cue Health, however, whipped up its ... |
| Feb 15, 2022 | Industry wants new European pharma makeover to increase the continent's attractiveness for R&D | Later this year, the European Commission is planning to release a major proposal to overhaul the continent’s general pharmaceutical legislation, as part of plans to boost the sector’s global competitiveness and create a regulatory environme... |
| Feb 14, 2022 | Bavarian Nordic lands breakthrough designation for RSV vaccine; Ucello closes Series A to advance CAR-T therapies | The FDA has granted Bavarian Nordic a Breakthrough Therapy Designation for its vaccine to prevent lower respiratory tract disease caused by respiratory syncytial virus.
The designation will allow Bavarian to work more closely with the FDA f... |
| Feb 14, 2022 | Looking for a quick diagnosis of your symptoms? This biotech is building an app for that | A digital health startup is adding to its cash cache as they hunt a more perfect app aimed at helping people quickly diagnose whatever ails them.
Nine months after digital health company Ada Health raised an initial $90 million in a Series ... |
| Feb 14, 2022 | GSK joins a crowd of pharma companies restricting sales under federal program | GlaxoSmithKline recently became the 14th biopharma company to switch up its approach to distributing drugs purchased via the federal 340B program for low-income individuals.
Effective April 1, GSK said it will ship products purchased at the... |
| Feb 14, 2022 | Akari Therapeutics to Present at BIO CEO & Investor Conference | NEW YORK and LONDON - Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biopharmaceutical company focused on innovative therapeutics to treat orphan autoimmune and inflammatory diseases where complement (C5) and/or leukotriene (LTB4) sys... |
| Feb 14, 2022 | Market issues prey on potential bounceback for antibiotics, says a new report — here's how to fix it | In the realm of drug R&D, the dramatic collapse of the antibiotics space — especially in light of the steady growth of antibiotic resistance — has been obvious for years now. And according to analysts at industry group BIO, it’s not bee... |
| Feb 14, 2022 | Covid-19 roundup: Despite treatment shortages, some US pharmacies report pile-ups of Merck's antiviral | The federal government has only sent four shipments of Merck’s Covid-19 antiviral molnupiravir (about 400,000 courses in each shipment) nationwide, and already HHS is reporting that some pharmacies are running out of space for the pill beca... |
| Feb 11, 2022 | Akari Therapeutics to Present at BIO CEO & Investor Conference | NEW YORK and LONDON, Feb. 11, 2022 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biopharmaceutical company focused on innovative therapeutics to treat orphan autoimmune and inflammatory diseases where complement (... |
| Feb 8, 2022 | GeoVax to Present at the 2022 BIO CEO & Investor Digital Conference | Atlanta, GA, Feb. 08, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company specializing in developing human vaccines and cancer immunotherapies, announced today that its Chairman and CEO,
Da... |
| Feb 7, 2022 | Plus Therapeutics to Present at BIO CEO & Investor Conference | AUSTIN, Texas, Feb. 07, 2022 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for rare and difficult-to-treat cancers, toda... |
| Feb 7, 2022 | KAZIA THERAPEUTICS TO PRESENT AT BIO CEO CONFERENCE | SYDNEY, Feb. 7, 2022 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce that CEO, Dr James Garner, will be presenting at the BIO CEO Conference, to be he... |
| Jan 31, 2022 | Immutep : to Present at February Investor Conferences | ASX/Media Release
Immutep to Present at February Investor Conferences
SYDNEY, AUSTRALIA - 31 January 2022 - Immutep Limited(ASX: IMM; NASDAQ: IMMP) ("Immutep" or "the Company"), a biotechnology company developing novel L... |
| Jan 6, 2022 | Salarius Pharmaceuticals to Present at Virtual H.C. Wainwright BioConnect, Participate in Virtual Biotech Showcase and BIO Partnering @ JPM During "J.P. Morgan Week 2022" | HOUSTON, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc, a clinical-stage biopharmaceutical company developing potential new medicines for patients with pediatric cancers, solid tumors, and other cancers, announced today th... |
| Dec 20, 2021 | Diffusion Pharmaceuticals to Present at H.C. Wainwright BioConnect, Participate in Biotech Showcase and Bio Partnering at JPM during “J.P. Morgan Week 2022” | CHARLOTTESVILLE, Va., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), a biopharmaceutical company developing novel therapies that enhance the body’s ability to deliver oxygen t... |
| Dec 9, 2021 | Viatris and Biocon mull pooling their biosimilars into a $10B standalone company — report | It appears to be open letter week in biotech.
On Sunday, Scripps Research’s Eric Topol penned a scathing letter in Medscape calling for FDA commissioner Stephen Hahn to resign after a series of alleged missteps and political concessions. An... |
| Aug 16, 2021 | ‘Stuck in a cul-de-sac’: Researchers are finally breaking away from the central dogma of depression | Geoffrey Attardo first tried Prozac to treat his depression when he was doing postdoctoral research at Yale School of Public Health and was feeling the pressures of a new job in academia. Soon after he started, the colors around him seemed ... |
| Jul 19, 2021 | Too close for comfort: FDA shouldn’t loosen conflict rules for its expert panels | Never mind the conflicts, there are drugs to approve.
In a sorry turn of events, the Food and Drug Administration is facing a confidence-draining debacle thanks to its controversial approval of a pricey Alzheimer’s drug for which evidence a... |
| Jun 30, 2021 | Men fill more than 9 in 10 biopharma CEO positions, an inequity that costs women more than $500 million in pay each year | An Insider analysis of 182 biotech and pharma companies revealed that 92% of CEOs are men.
The lack of diversity in the drug industry’s CEO ranks costs women an estimated $532 million a year.
Drug industry CEOs and other experts said equity... |
| Jun 8, 2021 | AZURRX BIOPHARMA, INC.
AzurRx BioPharma CEO James Sapirstein to Present at 2021 BIO Digital | BOCA RATON, Fla., June 08, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx” or the “Company”), a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastr... |
| Jun 7, 2021 | Meet the innovative Japanese life science companies from Yokohama participating in Bio Digital 2021 | For 2021, the BIO International Convention will be again held virtually as “BIO Digital.” This virtual gathering of the global biotech industry provides access to key partners via BIO’s One-on One Partnering system, educational resources to... |
| Jun 2, 2021 | PharmAbcine to Present at the BIO Digital International Convention 2021 | DAEJEON, South Korea, June 2, 2021 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of antibody therapeutics, announced today that the company will participate in BIO Digital ... |
| Jun 1, 2021 | CALADRIUS BIOSCIENCES, INC.
Caladrius Biosciences Announces Participation in Upcoming Conferences in June 2021 | BASKING RIDGE, N.J., June 01, 2021 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reve... |
| May 28, 2021 | Swiss deeptech startups get ready for June trade fairs | Innosuisse supports start-ups that are entering new markets and have huge potential on the world stage as well as a mature internationalisation strategy with its trade fair program. Every year several lead fairs are determined. In addition,... |
| May 28, 2021 | Swiss deeptech startups get ready for June trade fairs | |
| May 21, 2021 | To help solve climate change, look to the biosciences | President Biden’s pledge to cut U.S. greenhouse gas emissions in half by 2030 is an admirable and ambitious undertaking. It’s nearly double the goal set by President Obama in 2015. And it establishes the United States as a world leader in b... |
| May 19, 2021 | Beyond a symbolic gesture: What’s needed to turn the IP waiver into Covid-19 vaccines | The Biden administration’s announcement to support an intellectual property (IP) waiver for Covid-19 vaccines was a monumental step toward improving the access to them in low- and middle-income countries. But without further action, it will... |
| Mar 9, 2021 | Merck inks Keytruda deal with Surface Oncology; Rocket Pharmaceuticals gets expedited review of gene therapy for rare pediatric disease | Merck’s cash cow Keytruda has found another partner.
The pharma took the wraps off a collaboration deal on Tuesday to pair Keytruda with Surface Oncology’s IL-27 targeting antibody SRF388. The combo will be studied as ... |
| Feb 24, 2021 | Industry leaders need to speak out now more than ever | Biotech Voices is a collection of exclusive opinion editorials from some of the leading voices in biopharma on the biggest industry questions today. Think you have a voice that should be heard? Reach out to senior editors Kyle Blankenship a... |
| Feb 13, 2021 | Another Keytruda combo tops standard of care in advanced kidney cancer, posing new test for Bristol's I/O med | The biopharma industry, on the whole, had a red-letter year in 2020 amid Covid-19, with fundraising at an all-time high and major players speeding vaccines ahead to approval. But for BIO, the industry’s leading trade organization, the pande... |
| Jan 14, 2021 | As venture funding in oncology flourishes, neuro has seen shallower pockets. A European investor wants to change that | Big Pharma has retreated from neuroscience over the past several years, abandoning or trimming back programs after facing setbacks in difficult-to-treat brain disorders. And now, René Kuijten says dementia opportuni... |
| Sep 14, 2020 | Trump ups the stakes with 'granddaddy of them all' drug pricing executive order. But he could be running out of time | When President Donald Trump signed four executive orders in late July aiming at lowering drug prices, details of the most controversial — “the granddaddy of them all,” according to Trump — were conspicuously missing.... |
| Sep 3, 2020 | Let data – not politics – guide development of Covid-19 drugs, vaccines, biotech execs urge | A group of biotechnology leaders is urging biopharmaceutical companies in an open letter to ensure that the Food and Drug Administration remain independent and that development of new medicines for Covid-19 be free of political influence, w... |
| Sep 3, 2020 | Prominent biotech leaders release Covid-19 guidelines calling for FDA independence, data transparency | WASHINGTON — A group of prominent biotech CEOs are calling on their peers and the federal government to hold themselves to the highest standards when it comes to developing and reviewing Covid-19 treatments.
Among their demands: That biotec... |
| Jul 29, 2020 | What To Expect As Moderna’s Covid-19 Vaccine Moves To Phase 3 Trials | Medical syringe is seen with Moderna company logo displayed on a screen in the background in this ... [+] illustration photo taken in Poland on June 12, 2020. American biotech company Moderna has announced on June 11 that will start final s... |
| Jul 22, 2020 | Should Oxford-AstraZeneca’s Progress Worry Moderna? | a general view is pictured of the offices of British-Swedish multinational pharmaceutical and ... [+] biopharmaceutical company AstraZeneca PLC in Macclesfield, Cheshire on July 21, 2020. (Photo by Paul ELLIS / AFP) (Photo by PAUL ELLIS/AFP... |
| Jul 15, 2020 | What’s Happening With Moderna Stock? | BRAZIL - 2020/03/31: In this photo illustration Moderna logo is seen displayed on a smartphone. ... [+] (Photo Illustration by Rafael Henrique/SOPA Images/LightRocket via Getty Images)SOPA Images/LightRocket via Getty Images |
| Jul 7, 2020 | Why Has Moderna Stock Been Under Pressure Lately? | BRAZIL - 2020/03/24: In this photo illustration a Moderna logo seen displayed on a smartphone. ... [+] (Photo Illustration by Rafael Henrique/SOPA Images/LightRocket via Getty Images)SOPA Images/LightRocket via Getty Images |
